PT. Penta Valent Tbk (IDX:PEVE)
Indonesia · Delayed Price · Currency is IDR 510.00
-10.00 (-1.92%)
At close: Oct 30, 2025
PT. Penta Valent Tbk Revenue
PT. Penta Valent Tbk had revenue of 901.85B IDR in the quarter ending September 30, 2025, with 17.64% growth. This brings the company's revenue in the last twelve months to 3.41T, up 18.39% year-over-year. In the year 2024, PT. Penta Valent Tbk had annual revenue of 3.01T with 21.25% growth.
Revenue (ttm)
3.41T
Revenue Growth
+18.39%
P/S Ratio
0.26
Revenue / Employee
2.30B
Employees
971
Market Cap
882.81B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.01T | 528.07B | 21.25% |
| Dec 31, 2023 | 2.48T | 337.34B | 15.71% |
| Dec 31, 2022 | 2.15T | 359.31B | 20.10% |
| Dec 31, 2021 | 1.79T | 407.33B | 29.50% |
| Dec 31, 2020 | 1.38T | -50.49B | -3.53% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PT Kalbe Farma Tbk. | 34.38T |
| PT Enseval Putera Megatrading Tbk. | 32.20T |
| PT Tempo Scan Pacific Tbk | 13.48T |
| PT Siloam International Hospitals Tbk | 12.51T |
| PT Soho Global Health Tbk | 10.35T |
| PT Medikaloka Hermina Tbk | 6.98T |
| PT Mitra Keluarga Karyasehat Tbk | 5.24T |
| PT Industri Jamu dan Farmasi Sido Muncul Tbk | 3.85T |